Russell Investments Group, Ltd.
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1692234
Seattle, WA
Position in ARWR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$23,156,662
+$12,247,178 QoQ
Shares Held
284,096
+63.3% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#59
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. ARWR ranks #18 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,156,662 | 284,096 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $10,909,484 | 173,995 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $8,107,212 | 122,115 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $444,367 | 12,884 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $42,596 | 2,696 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $71,713 | 5,629 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,445,831 | 183,289 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,108,774 | 315,373 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,881,709 | 264,783 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $6,939,388 | 242,636 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $7,583,199 | 247,817 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $6,026,375 | 224,279 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,711,866 | 216,261 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $5,788,608 | 227,898 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $10,083,580 | 248,609 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,672,390 | 232,145 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $7,635,885 | 216,867 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $11,447,232 | 248,907 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $14,050,493 | 211,923 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $11,395,846 | 182,538 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $14,244,293 | 171,991 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $5,944,158 | 89,642 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $8,214,557 | 107,058 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,705,458 | 62,830 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,713,626 | 62,830 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $733,577 | 25,498 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||